Define Ventures published a portfolio spotlight on Valius Sciences, which uses advanced diagnostics to identify personalized treatment options for patients with rare and aggressive cancers.
Valius is a maximalist diagnostics company that thoroughly analyzes each patient's tumor DNA, RNA, and protein to assess all therapeutic targets, regardless of cancer type
Valius is a maximalist diagnostics company that thoroughly analyzes each patient's tumor DNA, RNA, and protein to assess all therapeutic targets, regardless of cancer type. They aim to find plausible therapeutic options for patients with challenging cancers.